Literature DB >> 32556358

Erosive Plaques with Excessive Granulation Tissue on the Scalp: A Quiz.

Anne-Guillemette Moineau1, Laurent Machet, Marianela Ackerman, Emmanuelle Blanchard, Claire Blechet, Antoine Finon.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32556358      PMCID： PMC9199917          DOI： 10.2340/00015555-3567

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  12 in total

1.  Rituximab for patients with refractory mucous membrane pemphigoid.

Authors:  Christelle Le Roux-Villet; Catherine Prost-Squarcioni; Marina Alexandre; Frédéric Caux; Francis Pascal; Serge Doan; Marie-Dominique Brette; Isaac Soued; Éric Gabison; Françoise Aucouturier; Rémi Letestu; Liliane Laroche; Hervé Bachelez
Journal:  Arch Dermatol       Date:  2011-03-21

2.  Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.

Authors:  J Daito; N Katoh; J Asai; E Ueda; H Takenaka; N Ishii; T Hashimoto; S Kishimoto
Journal:  Br J Dermatol       Date:  2008-07-15       Impact factor: 9.302

3.  Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II.

Authors:  S Fukuda; D Tsuruta; M Uchiyama; Y Mitsuhashi; H Kobayashi; T Ishikawa; B Ohyama; N Ishii; T Hamada; T Dainichi; T Karashima; T Nakama; S Yasumoto; T Hashimoto
Journal:  Br J Dermatol       Date:  2011-07-11       Impact factor: 9.302

4.  Epidermolysis Bullosa Acquisita (Brunsting-Perry Pemphigoid Variant) Localized to the Face and Diagnosed With Antigen Identification Using Skin Deficient in Type VII Collagen.

Authors:  Leila Asfour; Heung Chong; John Mee; Richard Groves; Manuraj Singh
Journal:  Am J Dermatopathol       Date:  2017-07       Impact factor: 1.533

5.  Anti-epiligrin cicatricial pemphigoid and relative risk for cancer.

Authors:  C A Egan; Z Lazarova; T N Darling; C Yee; T Coté; K B Yancey
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

6.  Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.

Authors:  R S Rogers; J R Seehafer; H O Perry
Journal:  J Am Acad Dermatol       Date:  1982-02       Impact factor: 11.527

Review 7.  Epitope spreading: lessons from autoimmune skin diseases.

Authors:  L S Chan; C J Vanderlugt; T Hashimoto; T Nishikawa; J J Zone; M M Black; F Wojnarowska; S R Stevens; M Chen; J A Fairley; D T Woodley; S D Miller; K B Gordon
Journal:  J Invest Dermatol       Date:  1998-02       Impact factor: 8.551

8.  Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.

Authors:  Philippe Bernard; Frank Antonicelli; Christophe Bedane; Pascal Joly; Christelle Le Roux-Villet; Sophie Duvert-Lehembre; Patricia Rousselle; Catherine Prost-Squarcioni
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

9.  Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure.

Authors:  Sachiko TAKEICHI; Yoshiaki KUBO; Seiji ARASE; Takashi HASHIMOTO; Shin-Ichi ANSAI
Journal:  Eur J Dermatol       Date:  2009-06-05       Impact factor: 3.328

10.  A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine.

Authors:  Noriko Tanaka; Teruki Dainichi; Bungo Ohyama; Shinichiro Yasumoto; Takashi Oono; Keiji Iwatsuki; Susanne Elfert; Anja Fritsch; Leena Bruckner-Tuderman; Takashi Hashimoto
Journal:  J Am Acad Dermatol       Date:  2009-08-13       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.